Trials / Completed
CompletedNCT04853225
Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China
Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,005 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This is a non-drug interventional cohort study, which aims to investigate the clinical, radiological and biological factors associated with disease progression in COPD in China. Participants will be recruited from multiple hospitals across Guangdong province categorized as Type A hospitals (those at prefecture-level and above) and Type B hospitals (those below prefecture-level).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prospective observational cohort study | Prospective observational cohort study |
Timeline
- Start date
- 2020-04-22
- Primary completion
- 2024-06-25
- Completion
- 2024-06-25
- First posted
- 2021-04-21
- Last updated
- 2025-08-20
- Results posted
- 2025-08-20
Locations
41 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04853225. Inclusion in this directory is not an endorsement.